Purpose Of Review: Gout is the most common inflammatory arthritis in the USA, affecting about 4% of all adults. The American College of Rheumatology (ACR) released a new guideline in 2020 to help with the management of gout. This guideline serves as an update to the previous set of guidelines which the ACR published in 2012. The purpose of this review is to compare the 2012 ACR gout guidelines to the newly released 2020 ACR gout guidelines.
Recent Findings: There are many similarities between the two guidelines, and also several key differences. The 2020 guidelines assist in the clinical management of gout by healthcare providers. Additionally, the new guidelines utilize newer literature to help create an evidence-based approach to the treatment for gout. We discuss the methodological approach to each guideline (RAND versus GRADE), as well as the final recommendations for gout flare treatment, use of imaging, urate-lowering therapy, lifestyle changes, and genetic testing prior to initiation of allopurinol in each guideline, as well as lingering issues that the 2020 guidelines have not addressed. We dissect both the 2012 and 2020 ACR gout guidelines to summarize the key similarities and differences between the two as well as discuss how the authors came to the recommendations that they did for each set of guidelines.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s11926-020-00967-8 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Pegloticase and Methotrexate Cotherapy in Patients With Uncontrolled Gout With Prior Pegloticase Monotherapy Failure: Findings of an Open-Label Trial.
ACR Open Rheumatol
January 2025
Amgen, Inc (formerly Horizon Therapeutics plc), Deerfield, Illinois.
Objective: Patients with uncontrolled gout have few treatment options. Pegloticase lowers serum urate (SU) levels, but antidrug antibodies limit SU-lowering response and increase infusion reaction (IR) risk. Methotrexate (MTX) cotherapy increases pegloticase response rates and lowers IR risk in pegloticase-naïve patients.
View Article and Find Full Text PDFClinical Images: Osteomyelitis complicating uncommon tophaceous gout: a case study with genetic findings.
ACR Open Rheumatol
January 2025
Radiology Unit, Santa Maria della Scaletta Hospital, Imola, Italy.
Performance of novel multiparametric second-generation dual-layer spectral detector CT in gouty arthritis.
Eur Radiol
November 2024
Department of Rheumatology and Immunology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Article Synopsis
- The study compares the effectiveness of various dual-energy CT (DECT) technologies for detecting monosodium urate (MSU) crystals in patients with gout.
- The research included diagnostic accuracy evaluations using both synovial fluid analysis and established gout classification criteria, finding that the new second-generation dlDECT showed the highest detection rate for MSU.
- Results indicated that the dlDECT technology, particularly the novel parameter CaSupp-I 25, has strong potential and may surpass other DECT methods in clinical value for gout diagnosis.
Development of a deep learning model for automated detection of calcium pyrophosphate deposition in hand radiographs.
Front Med (Lausanne)
October 2024
Department of Diagnostic and Interventional Radiology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland.
Article Synopsis
- CPPD disease is a significant cause of arthritis that can resemble other rheumatic conditions, making accurate diagnosis crucial.
- A deep-learning algorithm was developed and tested to automatically detect CPPD features in hand radiographs, focusing specifically on certain joint areas.
- The combined model for detecting CPPD showed strong performance metrics, with a mean AUROC of 0.86 and good sensitivity and specificity, while separate models for different joint areas had varying success rates.
Gout Flare Burden in the United States: A Multiyear Cross-Sectional Survey Study.
ACR Open Rheumatol
January 2025
Acumen Health Research Institute, Ann Arbor, Michigan.
Objective: The objective of this study was to assess the burden of gout flares and examine associated patient characteristics and outcomes in a sample of US adults.
Methods: Data were collected via an online survey of US adults ≥18 years using a random stratified sampling framework. Participants with gout completed questions about treatments, serum urate (SU) levels, severity, satisfaction with control, and gout flares.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!